Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [11C]Tariquidar and PET in Humans and Mice.
Hernández Lozano I, Bauer M, Wulkersdorfer B, Traxl A, Philippe C, Weber M, Häusler S, Stieger B, Jäger W, Mairinger S, Wanek T, Hacker M, Zeitlinger M, Langer O. Hernández Lozano I, et al. Among authors: zeitlinger m. Mol Pharm. 2020 Jan 6;17(1):316-326. doi: 10.1021/acs.molpharmaceut.9b01060. Epub 2019 Dec 17. Mol Pharm. 2020. PMID: 31790256 Free article.
[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.
Brunner M, Langer O, Dobrozemsky G, Müller U, Zeitlinger M, Mitterhauser M, Wadsak W, Dudczak R, Kletter K, Müller M. Brunner M, et al. Among authors: zeitlinger m. Antimicrob Agents Chemother. 2004 Oct;48(10):3850-7. doi: 10.1128/AAC.48.10.3850-3857.2004. Antimicrob Agents Chemother. 2004. PMID: 15388445 Free PMC article. Clinical Trial.
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET.
Langer O, Brunner M, Zeitlinger M, Ziegler S, Müller U, Dobrozemsky G, Lackner E, Joukhadar C, Mitterhauser M, Wadsak W, Minar E, Dudczak R, Kletter K, Müller M. Langer O, et al. Among authors: zeitlinger m. Eur J Nucl Med Mol Imaging. 2005 Feb;32(2):143-50. doi: 10.1007/s00259-004-1646-2. Epub 2004 Sep 4. Eur J Nucl Med Mol Imaging. 2005. PMID: 15690222 Clinical Trial.
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET.
Bauer M, Karch R, Neumann F, Abrahim A, Wagner CC, Kletter K, Müller M, Zeitlinger M, Langer O. Bauer M, et al. Among authors: zeitlinger m. Eur J Clin Pharmacol. 2009 Sep;65(9):941-6. doi: 10.1007/s00228-009-0709-5. Epub 2009 Aug 5. Eur J Clin Pharmacol. 2009. PMID: 19655132 Free PMC article.
A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET.
Wagner CC, Bauer M, Karch R, Feurstein T, Kopp S, Chiba P, Kletter K, Löscher W, Müller M, Zeitlinger M, Langer O. Wagner CC, et al. Among authors: zeitlinger m. J Nucl Med. 2009 Dec;50(12):1954-61. doi: 10.2967/jnumed.109.063289. Epub 2009 Nov 12. J Nucl Med. 2009. PMID: 19910428 Free PMC article. Clinical Trial.
360 results